NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹4.00 Cr | ₹3.23 Cr | ₹2.70 Cr | ₹2.55 Cr | ₹2.46 Cr |
What is the latest Long Term Provisions ratio of NGL FINECHEM ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹4.00 Cr |
| Mar2024 | ₹3.23 Cr |
| Mar2023 | ₹2.70 Cr |
| Mar2022 | ₹2.55 Cr |
| Mar2021 | ₹2.46 Cr |
How is Long Term Provisions of NGL FINECHEM Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.00 Cr | 24.02 | |
| Mar2024 | ₹3.23 Cr | 19.30 | |
| Mar2023 | ₹2.70 Cr | 6.04 | |
| Mar2022 | ₹2.55 Cr | 3.62 | |
| Mar2021 | ₹2.46 Cr | - | |
Compare Long Term Provisions of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,994.3 Cr | 5.5% | 3.3% | 147.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 5.5% |
3.3% |
147.7% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses